HARROW, INC. (HROW) insider trading

By person

13 insiders · 132 transactions

190×

Mark L. Baum holds 190 times base salary in stock. $143.77M of shares against $754.91K in salary for 2025.

Salary from the company's own proxy. The shares are what Mark L. Baum last reported holding, valued at $40.00, the price Common Stock was last bought or sold at on the open market here, on 14 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Mark L Baum

Chief Executive Officer

$1.18M (6)

—

+$1.18M

3,594,256

9.59%

$143.77M

+345.1%

Robert J Kammer

Director

—

$1.10M (17)

−$1.10M

797,327

2.13%

$31.89M

−26.8%

Martin A. Makary

Director

$672.65K (2)

—

+$672.65K

45,000

0.1200%

$1.80M

—

Richard L Md Lindstrom

Director

$179.00K (1)

$832.85K (5)

−$653.85K

216,100

0.5765%

$8.64M

+140.1%

Amir Shojaei

Chief Scientific Officer

—

$450.00K (1) scheduled

−$450.00K

0.0000%

$0.00

—

Opaleye Management Inc. entity

10% owner

$11.55M (59)

$11.79M (16)

−$242.56K

3,955,028

10.55%

$158.20M

+37.7%

Andrew R. Boll

President and CFO

$208.31K (3)

—

+$208.31K

814,679

2.17%

$32.59M

+5,331%

Adrienne L Graves

Director

$31.07K (1)

—

+$31.07K

1,000

0.0027%

$40.00K

—

Lauren P Silvernail

Director

$31.00K (1)

—

+$31.00K

1,000

0.0027%

$40.00K

—

Horn R. Lawrence Van

Director

$24.96K (1)

—

+$24.96K

1,860

0.0050%

$74.40K

—

John P. Saharek

CEO & President, ImprimisRx

—

467,388

1.25%

$18.70M

—

Anthony Principi

Director

—

93,798

0.2502%

$3.75M

—

Stephen G Austin

Director

—

91,987

0.2454%

$3.68M

+365.3%

HARROW, INC.

What the insiders did Balanced

By person